Cite
HARVARD Citation
Bittlinger, M. et al. (2021). Robust preclinical evidence in somatic cell genome editing: A key driver of responsible and efficient therapeutic innovations. Drug discovery today. 26 (10), pp. 2238-2243. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bittlinger, M. et al. (2021). Robust preclinical evidence in somatic cell genome editing: A key driver of responsible and efficient therapeutic innovations. Drug discovery today. 26 (10), pp. 2238-2243. [Online].